ROME Therapeutics
PrivateLast Round
Series B
Extension
Sep 12, 2023
Total Funding Raised
$199M
Company Overview
ROME Therapeutics is a biotechnology company focused on developing innovative therapies aimed at curing cancer and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ROME Therapeutics Comps
Public and private peers based on sector, stage, and business model.
ROME Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Sep 12, 2023 | ||||
| Series B | Sep 14, 2021 | ||||
| Series A | Apr 27, 2020 |
ROME Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Series B, Series B Extension |
| S32 | Series B Extension, Series B |
| GV | Series B, Series B Extension, Series A |
| Acks | Series B Extension |
| Eurofarma Ventures | Series B Extension |
| Mass General Brigham Innovation | Series A, Series B, Series B Extension |
| LUMA Partners | Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 23, 2025
Company is closing its physical headquarters to become entirely virtual.
- Sep 1, 2025
Company confirms layoffs planned for end of September 2025.
ROME Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about ROME Therapeutics's valuation, stock price, and market status.
